MFAS™ Platform
Myomics’ Myo-Force Assay System™ (MFAS™) uses human primary muscle cells tissue engineered into in vivo-like muscle fibers. Drug response can be quantified at a functional (contraction), tissue (hypertrophy) and biochemical (biomarkers) level. MFAS can be used to determine drug response over extended time periods (weeks or longer).